ArticleWorld journal of gastroenterology2018

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus.

Masayoshi Yada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.